Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
Burger
Daniel C
DC
Florin
Timothy H J
TH
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D016399:Lymphoma, T-Cell / Q000209:etiology* / Q000276:immunology; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab; D015122:Mercaptopurine